You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

LCZ696

Showing 26 - 50 of 66
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Tumor, Breast, Breast Diseases Trial in Poland (Sacubitril-valsartan)

Not yet recruiting
  • Breast Cancer
  • +12 more
  • Opole, Opolskie, Poland
  • +3 more
Jul 15, 2022

Heart Failure Trial in Cairo (myocardial function after surgery)

Recruiting
  • Heart Failure
  • myocardial function after surgery
  • Cairo, Egypt
  • +1 more
Oct 13, 2023

Hearth Failure With Reduced Ejection Fraction (HFrEF) Trial in Canada (LCZ696 (sacubitril/valsartan))

Completed
Has Results
  • Hearth Failure With Reduced Ejection Fraction (HFrEF)
  • LCZ696 (sacubitril/valsartan)
  • Edmonton, Alberta, Canada
  • +31 more
Mar 5, 2019

Heart Failure Trial in China (ACEI/ARB, ARNI)

Recruiting
  • Heart Failure
  • Hefei, An Hui, China
  • +24 more
Jun 30, 2022

CKD Trial (LCZ 696)

Unknown status
  • CKD
  • LCZ 696
  • (no location specified)
Dec 9, 2018

Obesity, Cardiovascular Diseases, Hypertension Trial in Birmingham (Sacubitril-Valsartan 49 Mg-51 Mg Oral Tablet, Valsartan 80

Recruiting
  • Obesity
  • +5 more
  • Sacubitril-Valsartan 49 Mg-51 Mg Oral Tablet
  • Valsartan 80 mg Oral Tablet
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jun 6, 2022

Resistant Hypertension, Blood Pressure Trial in Salvador (Sacubitril-Valsartan)

Recruiting
  • Resistant Hypertension
  • Blood Pressure
  • Salvador, Bahia, Brazil
  • +1 more
Nov 27, 2020

Resistant Hypertension Trial in Guangzhou (Sacubitril/valsartan, valsartan)

Recruiting
  • Resistant Hypertension
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Sep 16, 2022

Heart Failure With Preserved Ejection Fraction Trial in Worldwide (LCZ696, Valsartan)

Completed
Has Results
  • Heart Failure With Preserved Ejection Fraction
  • Huntsville, Alabama
  • +716 more
Sep 8, 2020

Hypertrophic Cardiomyopathy Trial in Worldwide (Lifestyle, Sacubitril/Valsartan)

Completed
  • Hypertrophic Cardiomyopathy
  • Regensburg, Germany
  • +4 more
Nov 23, 2022

Mitral Valve Insufficiency, Left Ventricular Dysfunction Trial in Incheon, Seoul (LCZ696, Valsartan)

Completed
  • Mitral Valve Insufficiency
  • Left Ventricular Dysfunction
  • Incheon, Korea, Republic of
  • +3 more
Jan 8, 2018

Hypertrophic Cardiomyopathy Trial in Newcastle (Sacubitril/Valsartan, Lifestyle)

Completed
  • Hypertrophic Cardiomyopathy
  • Newcastle, United Kingdom
    Newcastle NHS
May 4, 2022

Heart Failure With Preserved Ejection Fraction Trial (Sacubitril-Valsartan)

Withdrawn
  • Heart Failure With Preserved Ejection Fraction
  • (no location specified)
Aug 24, 2021

Chronic Heart Failure With Reduced Ejection Fraction Trial in Worldwide (LCZ696)

Completed
Has Results
  • Chronic Heart Failure With Reduced Ejection Fraction
  • LCZ696
  • Huntsville, Alabama
  • +396 more
Feb 19, 2019

Renal Hemodynamics in Patients With HFpEF

Completed
  • Heart Failure With Normal Ejection Fraction
  • Renal clearance examination
  • Erlangen, Germany
  • +1 more
Jul 8, 2019

Elevated Body Mass Index Trial in Lincoln (LIK066, Placebo)

Completed
Has Results
  • Elevated Body Mass Index
  • Lincoln, Nebraska
    Novartis Investigative Site
Dec 9, 2020

Atrial Fibrillation, Cardiac Remodeling, Atrial, Sacubitril/Valsartan Trial (Sacubitril-Valsartan, Valsartan)

Unknown status
  • Atrial Fibrillation
  • +2 more
  • (no location specified)
Mar 18, 2019

Essential Hypertension Trial in Worldwide (LCZ696, Olmesartan, Placebo of LCZ696)

Completed
Has Results
  • Essential Hypertension
  • LCZ696
  • +3 more
  • Beijing, Beijing, China
  • +49 more
Nov 8, 2016

Heart Failure NYHA Class I, Heart Failure NYHA Class II, Heart Failure NYHA Class III Trial in Nashville (Valsartan 80 mg bid,

Withdrawn
  • Heart Failure NYHA Class I
  • +2 more
  • Valsartan 80 mg bid
  • +4 more
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Jan 9, 2018

Hypertension Trial in Worldwide (LCZ696, Olmesartan, LCZ696 matching )

Completed
Has Results
  • Hypertension
  • LCZ696
  • +5 more
  • Clearwater, Florida
  • +46 more
Mar 31, 2016

Hypertension Trial in Moscow (LCZ696, Valsartan)

Completed
Has Results
  • Hypertension
  • Moscow, Russian Federation
    Novartis Investigative Site
Oct 20, 2015

Severe Hypertension Trial in Japan (LCZ696)

Completed
Has Results
  • Severe Hypertension
  • LCZ696
  • Yokohama-city, Kanagawa, Japan
  • +8 more
Oct 2, 2015

Hypertension Trial in Worldwide (LCZ696, Placebo)

Completed
Has Results
  • Hypertension
  • LCZ696
  • Placebo
  • Shijiazhuang, Hebei, China
  • +33 more
Jan 13, 2016

Mild to Moderate Hypertension Trial in Berlin (LCZ696, Sildenafil)

Completed
Has Results
  • Mild to Moderate Hypertension
  • Berlin, Germany
    Novartis Investigative Site
Oct 6, 2015

Mild and Moderate Renal Impairment Trial in Neuss, Moscow, Belgrade (LCZ696)

Completed
Has Results
  • Mild and Moderate Renal Impairment
  • LCZ696
  • Neuss, Germany
  • +2 more
Sep 25, 2015